Chargement en cours...

Should we treat acute hepatitis C? A decision and cost-effectiveness analysis

It is not standard practice to treat patients with acute hepatitis C virus (HCV) infection. However, as the incidence of HCV in the United States continues to rise, it may be time to re-evaluate acute HCV management in the era of direct-acting antiviral agents (DAAs). In this study a microsimulation...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatology
Auteurs principaux: Bethea, Emily, Chen, Qiushi, Hur, Chin, Chung, Raymond T., Chhatwal, Jagpreet
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826841/
https://ncbi.nlm.nih.gov/pubmed/29059461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29611
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!